Plan B or not to be, that is the question
The U.S. Food and Drug Administration (FDA) is still in the process of discussing over-the-counter status with Barr Pharmaceuticals, the maker of Plan B emergency contraception (ECP).
|
||||||||||||||||||||||||||
October 13, 2006
Volume 42, Issue 4